Double-Blind, Placebo-Controlled Trial of Octreotide Long-Acting Repeatable (LAR) in Thyroid-Associated Ophthalmopathy

• DOI: 10.1210/jc.2004-0697
• Publication Date: 2004-12-03T23:47:38Z
• Authors: A. Jane Dickinson; Bijay Vaidya; Margaret Miller; Alan Coulthard; Petros Perros; Elizabeth Baister; Christopher D. An...; Lutz Hesse; Johannes T. Hever...; Armin E. Heufelder; Pat Kendall-Taylor
• Keywords: Placebo-controlled study

Several uncontrolled studies suggest octreotide is beneficial in thyroid-associated ophthalmopathy (TAO); however, the natural tendency of TAO to improve mandates randomized, controlled trials.